New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy

OBJECTIVE: To assess the efficacy of biologic drugs, beyond tumor necrosis factor- (TNF-) α inhibitors, in the management of noninfectious refractory scleritis, either idiopathic or associated with systemic immune-mediated disorders. Patients and Methods. This is a retrospective study assessing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabiani, Claudia, Sota, Jurgen, Sainz-de-la-Maza, Maite, Pelegrín, Laura, Emmi, Giacomo, Lopalco, Giuseppe, Iannone, Florenzo, Vannozzi, Lorenzo, Guerriero, Silvana, Gelmi, Maria Chiara, Rigante, Donato, Tosi, Gian Marco, Hernández-Rodríguez, José, Cantarini, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201583/
https://www.ncbi.nlm.nih.gov/pubmed/32410867
http://dx.doi.org/10.1155/2020/8294560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201583/
https://www.ncbi.nlm.nih.gov/pubmed/32410867
http://dx.doi.org/10.1155/2020/8294560

Ejemplares similares